"At HonorHealth, our team members and physicians are focused on doing what’s right for our community. That is why we look more closely, go beyond the surface and see every dimension in everything we do, providing a level of care that defies the expected. And, we promise to not only live up to our name, but also follow through with action: Delivering care with integrity, respect and dedication to you."

During the past decade, HonorHealth Neurology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HonorHealth Neurology" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored, "Corbus Pharmaceuticals Inc." with 1 trials sponsored and "Mitsubishi Tanabe Pharma America Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HonorHealth Neurology" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "HonorHealth Neurology" are "Generalized Myasthenia Gravis" (2 trials), "ALS" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (1 trials) and "Dermatomyositis" (1 trials). Many other conditions were trialed in "HonorHealth Neurology" in a lesser frequency.

Most popular intervention types in "HonorHealth Neurology" are "Drug" (8 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Nipocalimab" (2 trials), "0.25% albumin placebo solution with rHuPH20" (1 trials), "Arimoclomol" (1 trials) and "Cemdisiran" (1 trials). Other intervention names were less common.

The vast majority of trials in "HonorHealth Neurology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "HonorHealth Neurology". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in HonorHealth Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HonorHealth Neurology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".